Saturday, 24 October 2015 12:41
Dapagliflozin reduces albuminuria on top of RAS blockade in type 2 diabetic patients with moderate renal impairment
Monday, 03 November 2014 00:25
Impact of SGLT2 inhibition in hypertension and diabetic nephropathy audioicon
Friday, 30 March 2012 13:40
The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy